A-to-I editing of the 5HT2C receptor and behaviour

Briefings in Functional Genomics and Proteomics

Volumn 5, Issue 1, 2006, Pages 37-42

  Gardiner, Katheleen ^a   Du, Yunzhi ^a  

^a UNIVERSITY OF DENVER   (United States)

Author keywords

Mouse strain; Protein isoforms; Psychiatric disorder; RNA editing; Serotonin signalling

Indexed keywords

ADENOSINE; AMINO ACID; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; INOSINE; ISOPROTEIN; MESSENGER RNA; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2C RECEPTOR; RNA PRECURSOR; SEROTONIN;

AMINO ACID SEQUENCE; ANIMAL BEHAVIOR; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CHEMICAL ANALYSIS; DEAMINATION; EXPERIMENTAL DESIGN; GENETIC CODE; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL STRESS; MOOD DISORDER; MOUSE STRAIN; NEUROMODULATION; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA EDITING; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUICIDE; ANIMAL; BEHAVIOR; GENETICS; METABOLISM; REVIEW;

MUS; RODENTIA;

ANIMALS; BEHAVIOR; BEHAVIOR, ANIMAL; HUMANS; RECEPTOR, SEROTONIN, 5-HT2C; RNA EDITING; RNA PRECURSORS; SEROTONIN;

EID: 33745958290     PISSN: 14739550     EISSN: 14774062     Source Type: Journal    
DOI: 10.1093/bfgp/ell006     Document Type: Article

References (21)

1. Maas S, Rich A, Nishikura K. A-to-I RNA editing: Recent news and residual mysteries. J Biol Chem 2003;278:1391.
2. Seeburg PH, Hartner J. Regulation of ion channel/neurotransmitter receptor function by RNA editing. Curr Opin Neurobiol 2003;13:279-83.
3. Nishikura K. Editing the message from A to 1. Nat Biotechnol 2004;22:962-63.
4. Eisenberg E, Nemzer S, Kinar Y, et al. Is abundant A-to-I RNA editing primate-specific? Trends Genet 2005;21:77-81.
5. Burns CM, Chu H, Rueter SM, et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997;387:303-8.
6. Herrick-Davis K, Grinde E, Niswender CM. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: Implications for serotonergic signal transduction. J Neurochem 1999;73:1711-7.
7. Niswender CM, Copeland SC, Herrick-Davis K, et al. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 1999; 274:9472-8.
8. Berg KA, Cropper JD, Niswender CM, et al. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 2001;134:386-92.
9. Wang Q, O'Brien PJ, Chen CX, et al. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 2000;74: 1290-300.
10. Niswender CM, Herrick-Davis K, Dilley GE, et al. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 2001;24:478-91.
11. Iwamoto K, Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 2003;346:169-72.
12. Sodhi MS, Burnet PW, Makoff AJ, et al. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry 2001;6:373-9.
13. Dracheva S, Elhakem SL, Marcus SM, et al. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 2003;87:1402-12.
14. Gurevich I, Tamir H, Arango V, et al. Altered editing of scrotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002;34:349-56.
15. Gurevich I, Englander MT, Adlersberg M, et al. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 2002;22: 10529-32.
16. Sodhi MS, Airey DC, Lambert W, etal. A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol 2005;68:711-9.
17. Englander MT, Dulawa SC, Bhansali P, et al. How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci 2005;25:648-51.
18. Iwamoto K, Nakatani N, Bundo M, et al. Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res 2005;53:69-76.
19. Cavallaro S, D'Agata V, Manickam P, et al. Memory-specific temporal profiles of gene expression in the hippocampus. Proc Natl Acad Sci USA 2002;99: 16279-84.
20. Bouwknecht JA, van der Gugten J, Groenink L, et al. Effects of repeated testing in two inbred strains on flesinoxan dose-response curves in three mouse models for anxiety. Eur J Pharmacol 2004;494:35-44.
21. Bouwknecht JA, Paylor R. Behavioral and physiological mouse assays for anxiety: A survey in nine mouse strains. Behav Brain Res 2002;136:489-501.